Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract PO4-15-12: Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancer

Mridula George, Trishala Meghal, Coral Omene, Ekaterina Kalashnikova, Janie Fielder, Nisha Ohri, Shicha Kumar, Valeria Burkovskaya, Preena Patel, Ashley Young, Melanie Racenstein, Tinamarie Bauman, Wassim Mchayleh, Deborah Toppmeyer, Shridar Ganesan, Barry Rosen, Angel Rodriguez, Minetta Liu

Cancer Res (2024) 84 (9_Supplement): PO4-15-12.

https://doi.org/10.1158/1538-7445.SABCS23-PO4-15-12

Published: 02 May 2024

View articletitled, Abstract PO4-15-12: Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancer

Journal Articles

Abstract P6-02-09: Racial/Ethnic Groups Have Different Rates of Pathogenic Variants in Common Cancer Genes

Cancer Res (2023) 83 (5_Supplement): P6-02-09.

https://doi.org/10.1158/1538-7445.SABCS22-P6-02-09

Published: 01 March 2023

View articletitled, Abstract P6-02-09: Racial/Ethnic Groups Have Different Rates of Pathogenic Variants in Common Cancer Genes

Journal Articles

Abstract P3-05-44: Genomic testing and Ki-67 Percentage: Two puzzle pieces being undervalued in breast cancer treatment

Cancer Res (2023) 83 (5_Supplement): P3-05-44.

https://doi.org/10.1158/1538-7445.SABCS22-P3-05-44

Published: 01 March 2023

View articletitled, Abstract P3-05-44: Genomic testing and Ki-67 Percentage: Two puzzle pieces being undervalued in breast cancer treatment

Journal Articles

Abstract P3-05-43: Germline Testing Results in Patients with Genomic Tumor Profiling

Cancer Res (2023) 83 (5_Supplement): P3-05-43.

https://doi.org/10.1158/1538-7445.SABCS22-P3-05-43

Published: 01 March 2023

View articletitled, Abstract P3-05-43: Germline Testing Results in Patients with Genomic Tumor Profiling

Journal Articles

Abstract 5906: Epidemiologic risk factors and survival trajectories among epithelial ovarian cancer survivors: A population-based cohort study

Shana Jean Kim, Barry Rosen, John R. McLaughlin, Harvey Risch, Shelly S. Tworoger, Steven A. Narod, Joanne Kotsopoulos

Cancer Res (2022) 82 (12_Supplement): 5906.

https://doi.org/10.1158/1538-7445.AM2022-5906

Published: 15 June 2022

View articletitled, Abstract 5906: Epidemiologic risk factors and survival trajectories among epithelial ovarian cancer survivors: A population-based cohort study

Journal Articles

Abstract 878: Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study

Yue Yin Xia, Jan Lubinski, Barry Rosen, Pal Moller, Andrea Eisen, Peter Ainsworth, Leigha Senter, Louise Bordeleau, Susan L. Neuhausen, Christian F. Singer, Jennifer Brooks, Ping Sun, Steven A. Narod, Joanne Kotsopoulos

Cancer Res (2021) 81 (13_Supplement): 878.

https://doi.org/10.1158/1538-7445.AM2021-878

Published: 01 July 2021

View articletitled, Abstract 878: Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study

Journal Articles

Abstract PS8-30: Longitudinal clinical outcomes of a multi-center universal genetic testing registry

Peter Beitsch, Rakesh Patel, Pat Whitworth, Barry Rosen, Rick Brown, Gia Compagnoni, Linsey Gold, Ian Grady, Edward Esplin, Sarah Nielsen, Max Brown, Melissa Trudrung, Chloe Wernecke, Mary Kay Hardwick, Robert Nussbaum

Cancer Res (2021) 81 (4_Supplement): PS8-30.

https://doi.org/10.1158/1538-7445.SABCS20-PS8-30

Published: 15 February 2021

View articletitled, Abstract PS8-30: Longitudinal clinical outcomes of a multi-center universal genetic testing registry

Journal Articles

Abstract P6-08-28: Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer

Cancer Res (2020) 80 (4_Supplement): P6-08-28.

https://doi.org/10.1158/1538-7445.SABCS19-P6-08-28

Published: 15 February 2020

View articletitled, Abstract P6-08-28: Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer

Journal Articles

Abstract B2-06: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy

Shengqing Gu, Stephanie Lheureux, Azin Sayad, Liat Frida Hogen, Iryna Vyarvelska, Paulina Cybulska, Marcus Bernardini, Barry Rosen, Amit Oza, Benjamin G. Neel

Cancer Res (2015) 75 (22_Supplement_2): B2-06.

https://doi.org/10.1158/1538-7445.COMPSYSBIO-B2-06

Published: 15 November 2015

View articletitled, Abstract B2-06: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy

Journal Articles

Abstract LB-307: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy

Shengqing Gu, Liat Hogen, Stephanie Lheureux, Azin Sayad, Iryna Vyarvelska, Paulina Cybulska, Marcus Bernardini, Barry Rosen, Amit Oza, Benjamin G. Neel

Cancer Res (2015) 75 (15_Supplement): LB-307.

https://doi.org/10.1158/1538-7445.AM2015-LB-307

Published: 01 August 2015

View articletitled, Abstract LB-307: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy

Journal Articles

Abstract #571: Mechanisms of regulation of the Kallekrein (KLK) gene family in ovarian carcinoma

Jane Bayani, Dionysios Katsaros, Cassandra Graham, Barry Rosen, Joan Murphy, Marcus Bernadini, Patricia Shaw, Jeremy Squire, Eleftherios Diamandis

Cancer Res (2009) 69 (9_Supplement): 571.

Published: 01 May 2009

View articletitled, Abstract #571: Mechanisms of regulation of the Kallekrein (KLK) gene family in ovarian carcinoma

Journal Articles

Abstract #181: Identification and characterization of serous ovarian cancer-initiating cells

Jocelyn Stewart, Patricia Shaw, James Greenaway, Barry Rosen, Benjamin Neel

Cancer Res (2009) 69 (9_Supplement): 181.

Published: 01 May 2009

View articletitled, Abstract #181: Identification and characterization of serous ovarian cancer-initiating cells

Journal Articles

The role of DAB2 and SKIL in high grade serous carcinoma

Alicia Tone, Heather Begley, Monika Sharma, Joan Murphy, Barry Rosen, Theodore Brown, Patricia Shaw

Cancer Res (2008) 68 (9_Supplement): 1732.

Published: 01 May 2008

View articletitled, The role of DAB2 and SKIL in high grade serous carcinoma

Journal Articles

Gene expression profiles linking serous low malignant potential tumor, with and without micropapillary features, to low grade serous carcinoma of the ovary

Taymaa May, Monika Sharma, Heather Begley, Igor Jurisica, Barry Rosen, K Joan Murphy, Patricia Shaw, Theodore Brown

Cancer Res (2008) 68 (9_Supplement): 1701.

Published: 01 May 2008

View articletitled, Gene expression profiles linking serous low malignant potential tumor, with and without micropapillary features, to low grade serous carcinoma of the ovary

Journal Articles

The study of fallopian tube epithelium to identify early events of hereditary serous carcinogenesis

Alicia Tone, Heather Begley, Monika Sharma, Igor Jurisica, Joan Murphy, Barry Rosen, Theodore Brown, Patricia Shaw

Cancer Res (2007) 67 (9_Supplement): 1170.

Published: 01 May 2007

View articletitled, The study of fallopian tube epithelium to identify early events of hereditary serous carcinogenesis

Journal Articles

Kallikreins as markers of disseminated tumour cells in ovarian cancer

Katerina Oikonomopoulou, Andreas Scorilas, Linda Grass, Antoninus Soosaipillai, Barry Rosen, Joan Murphy, Eleftherios P. Diamandis

Cancer Res (2005) 65 (9_Supplement): 1152.

Published: 01 May 2005

View articletitled, Kallikreins as markers of disseminated tumour cells in ovarian cancer

Journal Articles

Loss of Coordinated Androgen Regulation in Nonmalignant Ovarian Epithelial Cells with BRCA1/2 Mutations and Ovarian Cancer Cells

Andreas Evangelou, Michelle Letarte, Igor Jurisica, Mujahid Sultan, Kathleen J. Murphy, Barry Rosen, Theodore J. Brown

Cancer Res (2003) 63 (10): 2416–2424.

Published: 15 May 2003

View articletitled, Loss of Coordinated Androgen Regulation in Nonmalignant Ovarian Epithelial Cells with BRCA1/2 Mutations and Ovarian Cancer Cells

Journal Articles

Parallel Analysis of Sporadic Primary Ovarian Carcinomas by Spectral Karyotyping, Comparative Genomic Hybridization, and Expression Microarrays

Jane Bayani, James D. Brenton, Pascale F. Macgregor, Ben Beheshti, Monique Albert, Dhani Nallainathan, Jana Karaskova, Barry Rosen, Joan Murphy, Stephanie Laframboise, Brent Zanke, Jeremy A. Squire

Cancer Res (2002) 62 (12): 3466–3476.

Published: 01 June 2002

View articletitled, Parallel Analysis of Sporadic Primary Ovarian Carcinomas by Spectral Karyotyping, Comparative Genomic Hybridization, and Expression Microarrays

Includes: Supplementary data

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract PO4-15-12: Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancer

Abstract P6-02-09: Racial/Ethnic Groups Have Different Rates of Pathogenic Variants in Common Cancer Genes

Abstract P3-05-44: Genomic testing and Ki-67 Percentage: Two puzzle pieces being undervalued in breast cancer treatment

Abstract P3-05-43: Germline Testing Results in Patients with Genomic Tumor Profiling

Abstract 5906: Epidemiologic risk factors and survival trajectories among epithelial ovarian cancer survivors: A population-based cohort study

Abstract 878: Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study

Abstract PS8-30: Longitudinal clinical outcomes of a multi-center universal genetic testing registry

Abstract P6-08-28: Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer

Abstract B2-06: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy

Abstract LB-307: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy

Abstract #571: Mechanisms of regulation of the Kallekrein (KLK) gene family in ovarian carcinoma

Abstract #181: Identification and characterization of serous ovarian cancer-initiating cells

The role of DAB2 and SKIL in high grade serous carcinoma

Gene expression profiles linking serous low malignant potential tumor, with and without micropapillary features, to low grade serous carcinoma of the ovary

The study of fallopian tube epithelium to identify early events of hereditary serous carcinogenesis

Kallikreins as markers of disseminated tumour cells in ovarian cancer

Loss of Coordinated Androgen Regulation in Nonmalignant Ovarian Epithelial Cells with BRCA1/2 Mutations and Ovarian Cancer Cells

Parallel Analysis of Sporadic Primary Ovarian Carcinomas by Spectral Karyotyping, Comparative Genomic Hybridization, and Expression Microarrays

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only